Scientific publications

Aging Cell, 2025

Patterns of Organ‐Specific Proteomic Aging in Relation to Lifestyle, Diseases, and Mortality

Wang Q., Huang J., He Q. et al.

Journal of Affective Disorders, 2025

A novel potential biomarker panel to diagnose depression derived from big proteomic data

Ma S., Tan H., Zhang M. et al.

Critical Care Explorations, 2025

Aging and Host Responses to Severe Infection: Proteomic Analysis of a Prospective Multicenter Cohort From Uganda

Conte Cortez Martins G., Lutwama J., Owor N. et al.

Circulation: Heart Failure, 2025

Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy

Shah P., Zheng Y., Pieske B. et al.

Scientific Reports, 2025

Associations of the intestinal microbiota with plasma bile acids and inflammation markers in Crohn’s disease and ulcerative colitis

Prast-Nielsen S., Granström A., Kiasat A. et al.

Neurosurgical Review, 2025

Potential drug targets for intracranial aneurysms identified through Mendelian randomization analysis

Peng L., Peng H., Wu N. et al.

British Journal of Cancer, 2025

Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer

Wu W., Huang H., Zhu G. et al.

Journal of Proteome Research, 2025

Discovering Biomarkers for Asymptomatic Tuberculosis via Olink Proteomics and Machine Learning

Sun Q., Li S., Ren W. et al.

Allergy, 2025

Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses

Zhang Y., Pi J., Wang L. et al.

Open Forum Infectious Diseases, 2025

Two or three? Clinical and proteomic perspectives on dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide as initial HIV treatment

Díaz-García C., Serrano-Villar S., de Morales A. et al.

Medicine, 2025

Gut microbiota influences lung cancer risk through circulating cytokines—Insights from a Mendelian randomization study

Shen W., Hou R., Zhang J. et al.

The Journal of Clinical Endocrinology & Metabolism, 2025

Association of urinary copper and gestational diabetes mellitus: role of epigenome-wide DNA methylation and proteomics

Li Y., Zhang S., Lai Y. et al.

Brain, 2025

Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers

Karlsson L., Janelidze S., Barthélemy N. et al.

BMC Medicine, 2025

Efficacy, safety, and exploratory biomarker analysis of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: a prospective, single-arm, phase II trial

Zhao X., Zhang J., Qiu L. et al.

BMC Nephrology, 2025

Association of Osteopontin and selective glomerular hypofiltration syndrome with hospitalization for kidney failure in acute heart failure patients

Ohlsson M., Nilsson C., Molvin J. et al.

Current Medicinal Chemistry, 2025

Mediating Effects of Plasma Metabolites in Inflammatory Protein-Lymphoma Causality: A Mendelian Randomization Study

Ji Y., Gao X., Liu L. et al.

Multiple Sclerosis and Related Disorders, 2025

Proteomics confirms immune stabilizing effects of narrowband UVB treatment in patients with clinically isolated syndrome and multiple sclerosis

Hart P., Emig C., Obeidat A. et al.

Cell Genomics, 2025

Multi-omic underpinnings of heterogeneous aging across multiple organ systems

Xiong J., Zhu X., Guo Y. et al.

Journal of Inflammation Research, 2025

Clinical Features, Treatment Effectiveness and Long-Term Outcomes in Children with Moderate-to-Severe Generalized Pustular Psoriasis: A Retrospective Cohort Study

Cao Z., Peng B., Li Z. et al.

GeroScience, 2025

Immune cells and inflammatory proteins are differentially associated with subsequent DNA methylation biological aging measures in the Framingham Heart Study Offspring Cohort

Rotti L., Murabito J., Chen J. et al.